ALPS ADVISORS INC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,074,185
+9.2%
41,008
+0.8%
0.02%
+6.2%
Q2 2023$1,898,649
+61.0%
40,665
+32.0%
0.02%
+60.0%
Q1 2023$1,178,944
-32.2%
30,814
-2.9%
0.01%
-37.5%
Q4 2022$1,738,530
+148.4%
31,725
+54.4%
0.02%
+128.6%
Q3 2022$700,000
+257.1%
20,548
-1.1%
0.01%
+250.0%
Q2 2022$196,000
-61.6%
20,777
-42.3%
0.00%
-66.7%
Q1 2022$511,000
-40.2%
35,984
-10.9%
0.01%
-40.0%
Q4 2021$854,000
-10.6%
40,373
-5.5%
0.01%
+11.1%
Q3 2021$955,000
-16.1%
42,729
-6.9%
0.01%
-10.0%
Q2 2021$1,138,000
-37.5%
45,872
-27.0%
0.01%
-44.4%
Q1 2021$1,822,000
+12.6%
62,814
+0.1%
0.02%0.0%
Q4 2020$1,618,000
+18.8%
62,722
+41.7%
0.02%
-10.0%
Q3 2020$1,362,000
+39.7%
44,249
+13.1%
0.02%
+53.8%
Q2 2020$975,000
-11.4%
39,113
-24.7%
0.01%
-23.5%
Q1 2020$1,101,000
-14.5%
51,918
-10.4%
0.02%
+70.0%
Q4 2019$1,287,00057,9750.01%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders